期刊文献+

多发性骨髓瘤使用双磷酸盐引起颌骨坏死的探讨与护理 被引量:2

原文传递
导出
摘要 目的探讨双膦酸盐相关颌骨坏死的危险因素、发生率、预防、治疗和护理。方法报道2例多发性骨髓瘤(MM)患者使用双磷酸盐致颌骨坏死的临床表现、治疗经过及护理,分析其发病的危险因素、预防措施、治疗策略及护理。结果2例确诊MM患者,在联合化疗加沙利度胺的基础上,分别于使用帕米磷酸二钠治疗12个月和50个月后出现右上颌及左下颌颌骨坏死(ONJ),1例患者发病前有拔牙史。经停用双磷酸盐,全身使用抗生素并醋酸氯已定漱口,脓肿治愈。结论静脉应用双膦酸盐可以延缓骨相关并发症,但是应该重视其应用后产生的颌骨坏死等副作用以及加强口腔护理。
作者 杨便红
出处 《中华现代护理杂志》 2009年第15期1449-1450,共2页 Chinese Journal of Modern Nursing
  • 相关文献

参考文献5

  • 1Marx RE. Pamidronate ( Aredia ) and zoledronate ( Zometa ) induced avascular necrosis of the jaws:a growing epidemic. J Oral Maxillofac Surg,2003,61 : 1115-1118.
  • 2方强.危重病护理学.杭州:浙江大学出版社,2001.
  • 3Bagan JV, Murillo J, Jimenez Y, et al. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med ,2005,34 : 120-123.
  • 4Pires FR, Miranda AMMA, Cardoso ES, et al. Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy. Oral Diseases ,2005,11:365-369.
  • 5Ruggiero SL, Gralow J, Marx RE, et al. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Practice,2006,2:7-14.

共引文献4

同被引文献23

  • 1Hansen T, Kirkpatrick CJ, Waiter C, et ai. Increased numbers of osteoclasts expressing cysteine proteinase cathepsin K in patients with infected osteoradionecrosis and bisphosphonate : associated osteonecrosis : a paradoxical observation[J].Virchows Arch, 2006, 449(4):448-454.
  • 2Kuroshima S, Go VA, Yamashita J. Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice[J]. Endocrinology, 2012,153(1):17-28.
  • 3Vigorita VJ, Silver JS, Eisemon EO. Osteoclast abnormalities in fractured bone during bisphosphonate treatment for osteoporosis: a case report[J].Skeletai Radiol, 2012, 41(7): 861-865.
  • 4Hansen T, Kunkel M, Weber A, et al. Osteonecrosis of thejaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis[J].J Oral Pathol Med, 2006, 35(3):155-160.
  • 5Cornish J, Bava U, Callon KE, et al. Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells[J]. Bone, 2011, 49(4):710-716.
  • 6Stefanik D, Satin J, Lam T, et al. Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate[J].Oral Dis,2008,14(5):465-471.
  • 7Seguin C, Kassis J, Busque L, et al. Non-traumatic necrosis of bone (osteonecrosis) is associated with endothelial cell activation but not thrombophilia[J].Rheumatology (Oxford), 2008,47 (8): 1151 - 1155.
  • 8Allen MR, Burr DB. The pathogenesis of bisphosphonate- related osteoneerosis of the jaw: so many hypotheses, so few data[J].J Oral Maxillofae Surg, 2009, 67(5 Suppl):61-70.
  • 9Mashiba T, Hirano T, Turner CH, et al. Suppressed bone turnover by bisphosphonates increases mierodamage aecumulation and reduces some biomeehanieal properties in dog rib[J]. J Bone Miner Res, 2000, 15(4):613-620.
  • 10Fournier P, Boissier S, Filleur S, et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats[J]. Cancer Res, 2002, 62(22):6538-6544.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部